Capital World Investors Seagen Inc. Transaction History

Capital World Investors

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$191.51 - $216.16 $1.29 Billion - $1.45 Billion	-6,721,694 Reduced 74.02%	2,359,715 $501 Million
Q2 2023 Aug 11, 2023	SELL	$187.64 - $206.25 $598 Million - $658 Million	-3,188,031 Reduced 25.98%	9,081,409 $1.75 Billion
Q1 2023 May 15, 2023	BUY	$127.59 - $203.08 $639 Million - $1.02 Billion	5,009,389 Added 69.0%	12,269,440 $2.48 Billion
Q4 2022 Feb 14, 2023	BUY	$117.37 - $139.17 $302 Million - $359 Million	2,577,095 Added 55.03%	7,260,051 $933 Million
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $154 Million - $205 Million	1,137,895 Added 32.1%	4,682,956 $641 Million
Q2 2022 Aug 15, 2022	BUY	$108.81 - $179.33 $386 Million - $636 Million	3,545,061 New	3,545,061 $627 Million
Q1 2021 May 14, 2021	SELL	$137.51 - $190.8 $24.7 Million - $34.3 Million	-179,616 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$164.63 - $211.93 $29.6 Million - $38.1 Million	179,616 New	179,616 $31.5 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

Stay updated on Capital World Investors with notifications on news.